Throughout its 10-year partnership with distributor LAS Brasil, Graftys has achieved the milestone of 10,000 units of GRAFTYS® HBS sold in Brazil as of 3Q20.
Graftys Syringe and Cannula
GRAFTYS HBS is a calcium phosphate bone graft substitute, offering very low viscosity to facilitate remote injections into closed bone cavities. The macroporous, resorbable, self-hardening cement features an all-in-one closed double-compartment preparation and injection system. Compared with other injectable cements, GRAFTYS HBS offers a mechanical resistance similar to that of trabecular bone while being fast resorbed and replaced by new quality bone.
Enrico Bastianelli, Chief Executive Officer of Graftys, said, “We’d like to thank LAS Brasil’s team for this incredible achievement and their outstanding contribution over the past 10 years. Such long-term partnerships associated with strong sales records prove our commitment to continuously search for the best solution for the surgeons’ and patients’ medical needs. We are looking forward to the next 10 years’ collaboration!”
Throughout its 10-year partnership with distributor LAS Brasil, Graftys has achieved the milestone of 10,000 units of GRAFTYS® HBS sold in Brazil as of 3Q20.
GRAFTYS HBS is a calcium phosphate bone graft substitute, offering very low viscosity to facilitate remote injections into closed bone cavities. The macroporous, resorbable,...
Throughout its 10-year partnership with distributor LAS Brasil, Graftys has achieved the milestone of 10,000 units of GRAFTYS® HBS sold in Brazil as of 3Q20.
Graftys Syringe and Cannula
GRAFTYS HBS is a calcium phosphate bone graft substitute, offering very low viscosity to facilitate remote injections into closed bone cavities. The macroporous, resorbable, self-hardening cement features an all-in-one closed double-compartment preparation and injection system. Compared with other injectable cements, GRAFTYS HBS offers a mechanical resistance similar to that of trabecular bone while being fast resorbed and replaced by new quality bone.
Enrico Bastianelli, Chief Executive Officer of Graftys, said, “We’d like to thank LAS Brasil’s team for this incredible achievement and their outstanding contribution over the past 10 years. Such long-term partnerships associated with strong sales records prove our commitment to continuously search for the best solution for the surgeons’ and patients’ medical needs. We are looking forward to the next 10 years’ collaboration!”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
